ADAGENE

adagene-logo

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.

#SimilarOrganizations #People #Financial #Event #Website #More

ADAGENE

Social Links:

Industry:
Biotechnology Medical Oncology Therapeutics

Founded:
2011-01-01

Address:
Suzhou, Jiangsu, China

Country:
China

Website Url:
http://www.adagene.com

Total Employee:
51+

Status:
Active

Contact:
+051287773632

Email Addresses:
[email protected]

Total Funding:
155 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Font API Google Tag Manager WordPress Google Analytics Amazon SSL By Default


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

arcturus-therapeutics-logo

Arcturus Therapeutics

Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

innolake-biopharm-logo

Innolake Biopharm

Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.

leap-therapeutics-logo

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

tot-biopharm-logo

TOT BIOPHARM

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.

trymed-logo

Trymed

Trymed is a clinical research company that seeks new treatments in oncology and other therapeutic areas.


Current Advisors List

not_available_image

Robert Spiegel Members Scientific and Strategic Advisory Board @ Adagene
Advisor
2021-08-01

stanley-frankel_image

Stanley Frankel Members Scientific and Strategic Advisory Board @ Adagene
Advisor
2021-08-01

Current Employees Featured

yan-li_image

Yan Li
Yan Li Vice President of Bioinformatics and Information Technology @ Adagene
Vice President of Bioinformatics and Information Technology

steven-fischkoff_image

Steven Fischkoff
Steven Fischkoff Interim Chief Medical Officer @ Adagene
Interim Chief Medical Officer
2021-06-01

kristine-she_image

Kristine She
Kristine She Vice President of Operations @ Adagene
Vice President of Operations

felix-du_image

Felix Du
Felix Du Vice President of Technology Development @ Adagene
Vice President of Technology Development

Stock Details


Company's stock symbol is NASDAQ:ADAG

Investors List

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series D - Adagene

eight-roads-ventures_image

Eight Roads Ventures

Eight Roads Ventures investment in Series D - Adagene

wuxi-venture-capital-group_image

Wuxi Venture Capital Group

Wuxi Venture Capital Group investment in Series D - Adagene

general-atlantic_image

General Atlantic

General Atlantic investment in Series D - Adagene

sequoia-capital-china_image

Sequoia Capital China

Sequoia Capital China investment in Series D - Adagene

gopher-asset-management_image

Gopher Asset Management

Gopher Asset Management investment in Series C - Adagene

new-world-tmt-ltd_image

New World TMT Ltd

New World TMT Ltd investment in Series C - Adagene

avic-trust_image

AVIC Trust

AVIC Trust investment in Series C - Adagene

sequoia-capital-china_image

Sequoia Capital China

Sequoia Capital China investment in Series C - Adagene

king-star-capital_image

King Star Capital

King Star Capital investment in Series C - Adagene

Official Site Inspections

http://www.adagene.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.59 K

  • Host name: ec2-52-42-95-121.us-west-2.compute.amazonaws.com
  • IP address: 52.42.95.121
  • Location: Boardman United States
  • Latitude: 45.8491
  • Longitude: -119.7143
  • Metro Code: 810
  • Timezone: America/Los_Angeles
  • Postal: 97818

Loading ...

More informations about "Adagene"

Company Overview - Adagene

Our discovery engine, Dynamic Precision Library, is driving Adageneโ€™s pipeline of programs with potential to be first or best in class. We have forged strategic partnerships with multiple reputable global companies. These partnerships โ€ฆSee details»

Adagene - Crunchbase Company Profile & Funding

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which โ€ฆSee details»

Investor Relations โ€“ Adagene Inc.

Feb 27, 2025 Adagene (NASDAQ: ADAG) is a publicly traded, global, clinical-stage biopharmaceutical company committed to transforming the discovery and development of โ€ฆSee details»

Adagene - LinkedIn

Adagene Inc. (Nasdaq: ADAG) is a biotechnology company transforming the discovery and development of novel antibody-based cancer immunotherapies.See details»

Adagene Inc. (ADAG) Company Profile & Facts - Yahoo Finance

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates โ€ฆSee details»

Careers - Adagene

Adagene is an equal opportunity employer that is committed to diversity and inclusion. We prohibit discrimination and harassment of any kind based on race, color, religion, sex, sexual โ€ฆSee details»

Adagene - Funding, Financials, Valuation & Investors - Crunchbase

Adagene is registered under the ticker NASDAQ:ADAG . Their stock opened with $19.00 in its Feb 9, 2021 IPO. Adagene is funded by 11 investors. ... How much funding has this โ€ฆSee details»

Adagene Company Profile - Office Locations, Competitors ... - Craft

Oct 29, 2024 Adagene has 5 employees across 3 locations and $18.11 m in annual revenue in FY 2023. See insights on Adagene including office locations, competitors, revenue, financials, โ€ฆSee details»

Adagene Reports Full Year 2024 Financial Results and Provides โ€ฆ

5 days ago Wang has served on Adageneโ€™s Board since 2023 and provided invaluable guidance as Adagene has developed ADG126 through first-in-human clinical trials. Mervyn Turner , โ€ฆSee details»

Adagene - Contacts, Employees, Board Members, Advisors & Alumni

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience โ€ฆSee details»

Adagene, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Feb 25, 2025 Adageneโ€™s lead clinical program, ADG126 (muzastotug), is a masked, anti-CTLA-4 SAFEbody that targets a unique epitope of CTLA-4 in regulatory T cells (Tregs) in the tumor โ€ฆSee details»

Adagene - Overview, News & Similar companies | ZoomInfo.com

Adagene is a clinical stage biotech company with innovative antibody discovery and engineering technologies. This company develops immuno-oncology antibodies against novel epitopes that โ€ฆSee details»

Company Adagene Inc. BOERSE MUENCHEN - MarketScreener.com

Feb 27, 2025 Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer โ€ฆSee details»

About - Adagene

Toggle navigation. ็ฎ€ไฝ“ไธญๆ–‡. English; ็ฎ€ไฝ“ไธญๆ–‡See details»

News Releases - Adagene Inc.

Jan 27, 2025 Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO โ€ฆSee details»

Company Adagene Inc. - MarketScreener.com

Jan 31, 2018 Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer โ€ฆSee details»

Adagene Reports Full Year 2024 Financial Results and Provides โ€ฆ

4 days ago Net loss attributable to Adagene Inc.โ€™s shareholders (18,946,370 ) (33,424,111 ) Other comprehensive income (loss) Foreign currency translation adjustments, net of nil tax โ€ฆSee details»

SAFEbody - Adagene

SAFEbody ® is our proprietary precision antibody masking platform designed to enable an antibody to bind its target specifically only after conditional activation of the antibody in target โ€ฆSee details»

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 โ€ฆ

Jul 12, 2024 Adageneโ€™s lead clinical program, ADG126 (muzastotug), is a masked, anti-CTLA-4 SAFEbody that targets a unique epitope of CTLA-4 in regulatory T cells (Tregs) in the tumor โ€ฆSee details»

Adagene Reports Full Year 2024 Financial Results and Provides โ€ฆ

3 days ago SAN DIEGO, SUZHOU, China - Adagene Inc. (' Adagene ') (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and โ€ฆSee details»

linkstock.net © 2022. All rights reserved